Stocks and securities

Stocks and securities

X
X

Stocks and securities

Stocks and securities

X
X

Lactose (India) Ltd
  • Symbol: Not Listed
  • |
  • BSE Code: 524202
  • |
  • Sector:PHARMACEUTICALS - INDIAN - BULK DRUGS
40.09 -2.64 (-6.18%)

29-Mar-2023 | 12:00

Open 43.90

High 43.90

Low 39.25

Previous Close 42.73

52 week Low 96.35

52 week High 39.25

Traded Volume (Lacs) 1,562.50

Traded Value (Cr) 225.00

Volume(Lacs) 34,703

Dividend Yield 0

Market Cap(Cr) 50.47

Face Value 10.00

EPS 2.3

  • Symbol: Not Listed
  • |
  • BSE Code: 524202
  • |
  • Sector:PHARMACEUTICALS - INDIAN - BULK DRUGS

Open 43.90

High 43.90

Low 39.25

Previous Close

52 week High

52 week Low

Traded Volume 156,250,255.00

Traded Value (Cr) 225.00

Volume(Lacs) 34,703

Dividend Yield 0

Market Cap(Cr) 50.47

Face Value 10.00

EPS 2.3

COMPANY INFO

Lactose (India) Ltd is an India-based company. The company is engaged in the manufacturing and trading of pharmaceutical products. They offer edible and pharmaceutical grade lactose, which is used as an ingredient in pharmaceutical products, as well as in the dairy, food, confectionery, and beverage industries. The company also manufactures dairy whitener, dairy calcium, whey powder, casein, caseinate, butter, and ghee. Further, they engage in the contract manufacture of pharmaceutical products.

The company is having their manufacturing facilities located at Vadodara in Gujarat. This state of art manufacturing facilities for the manufacture of pharmaceutical formulations is in compliance with all international standards. The manufacturing facilities include wet granulation, Fluid bed drying, compaction, blending and coating facilities with the latest technology equipments. The company is well backed up by its excellent network of indenting agents in India i.e. Mumbai, Delhi, Chennai, Bangalore, Calcutta, Hyderabad and Ahmedabad.

Lactose (India) Ltd was incorporated on March 1991 as a public limited company in the Vadodara district of Gujarat. The company set up a project to manufacture lactose IP/BP grade, an import substitute, with an installed capacity of 465 tpa at an estimated cost of Rs 4.5 crore. The unit was commissioned by Alfa Laval, Pune, a subsidiary of Alfa Laval, Sweden. In January 1994, the company commenced commercial production of Lactose.

In the year 1994, the company undertook an expansion and forward integration programme involving the capacity expansion of lactose from 465 tpa to 1500 tpa. They also set up of a pharmaceutical formulation plant with three sections, namely capsule section, tablet section and indictable section.

During the year 1995-96, the company started processing sweetened condenced milk for domestic supply and acid casein for exports. They had started the job work of condenced milk casein powder.

During the ye

Turnover (₹. Cr.)1,409,097.00

Market cap(₹. Cr.) 50.47

Open price : 43.90

Prev.Close : 42.73

Today High / Low

mrkt-high-low 43.90 39.25

52 week High / LOW

mrkt-high-low 96.35 39.25

194.80

+0.95 (+0.49%) 26 Nov 2020 | 03:14

Loading

Turnover (₹. Cr.)

Market cap(₹. Cr.)

Open price :

Prev.Close :

Today High / Low

mrkt-high-low

52 week High / LOW

mrkt-high-low
Last 5 days
bar

29-Mar-2023 BSE

-2.64 (-6.18%)

  • Close Price

    40.09

  • Volume

    34703

bar

28-Mar-2023 BSE

0.73 (1.74%)

  • Close Price

    42.73

  • Volume

    7475

bar

27-Mar-2023 BSE

-6.00 (-12.50%)

  • Close Price

    42

  • Volume

    8418

bar

24-Mar-2023 BSE

1.75 (3.78%)

  • Close Price

    48

  • Volume

    16

bar

23-Mar-2023 BSE

0.53 (1.16%)

  • Close Price

    46.25

  • Volume

    5882

1 YEAR RETURN - UNDERPERFORMED THE SENSEX BY 28.76%
  • Stock Absolute
  • -8.29
  • -7.01
  • -28.72
  • 167.06
  • -57.94
  • Returns
  • 1W
  • 1M
  • 1Y
  • 3Y
  • 5Y
  • Sensex Absolute
  • -0.79
  • -2.29
  • 0.04
  • 102.58
  • 74.75
NEWS

{{d.caption}} {{d.date}}

SUPPORT RESISTANCE
PIVOT POINT
Support
Support 1 NA
Support 2 NA
Support 3
FINANCIAL DATA
Loading
Column Name MAR 2020 MAR 2019 MAR 2018
{{d.co_name}} {{d.RecordDate2}} {{d.RecordDate3}} {{d.RecordDate4}}
Column Name MAR 2020 MAR 2019 MAR 2018
{{d.co_name}} {{d.RecordDate2}} {{d.RecordDate3}} {{d.RecordDate4}}
ParticularsDec 2022(₹.Cr)Sep 2022(₹.Cr)Jun 2022(₹.Cr)
Gross Sales 17.0213.179.62
Excise Duty 000
Net Sales 17.0213.179.62
Other Operating Income 000
Other Income  0.160.200.23
CATEGORY NO. OF SHARES PERCENTAGE (%)
Total Foreign {{d.NO_S_FO}} {{d.PER_S_FO}}
Total Institutions {{d.NO_S_INST}} {{d.PER_S_INST}}
Total Govt Holding {{d.NO_S_GOV}} {{d.PER_S_GOV}}
Total Non Promoter Corporate Holding {{d.NO_S_CH}} {{d.PER_S_CH}}
Total Promoters {{d.NO_S_PRO}} {{d.PER_S_PRO}}
Total Public & others {{d.TotNo_Pro}} {{d.TotPer_Pro}}
Total {{d.TotShares}} {{d.TotSharePer}}
CORPORATE ACTIONS
RECORD DATE EX-BONUS DATE RATIO
{{d.RecordDate}} {{d.BonusDate}} {{d.BonusRatio}}
RECORD DATE Split Date Face Value Before Face Value After
{{d.RecordDate}} {{d.SplitDate}} {{d.FVBefore}} {{d.FVAfter}}
Announcement Date Ex Dividend Date Dividend (%) Dividend Type
{{d.AnnouncementDate}} {{d.DivDate}} {{d.DivPer}} {{d.remark}}
Premium () Ratio Record Date Ex Rights Date
{{d.premium}} {{d.Ratio}} {{d.recordDate}} {{d.RightDate}}
dfsdf1
From Date Announcement
{{d.BCFromdate}} {{d.Agenda}}
Explore abtrade Mobile investplaystoreappstore
Lactose (India) Ltd
  • Symbol: Not Listed
  • |
  • BSE Code: 524202
  • |
  • Sector:PHARMACEUTICALS - INDIAN - BULK DRUGS

29-Mar-2023 | 12:00

Open 39,949.95

High 40,311

Low 39,869.85

Previous Close 39,853.80

Strike Price 0.00

Open Interest(Nos.) 3,572,325.00

OI Change % 25.67

Volume(Lacs) 25.67

Lot Size 25.00

Average Price 40,102.32

OI Difference 729,800.00

Previous OI 2,842,525.00

Turnover (₹. Cr.) 121,707,000,178.75

Open price :39,949.95

Prev.Close :39,853.80

Today High / Low

mrkt-high-low 40,311 39,869.85
Explore abtrade Mobile investplaystoreappstore
Lactose (India) Ltd
  • Symbol: Not Listed
  • |
  • BSE Code: 524202
  • |
  • Sector:PHARMACEUTICALS - INDIAN - BULK DRUGS

29-Mar-2023 | 12:00

Open 550.90

High 860

Low 535.80

Previous Close 511.90

Strike Price 39,100.00

Open Interest(Nos.) 39,350.00

OI Change % -67.02

Volume(Lacs) -67.02

Lot Size 25.00

Average Price 662.00

OI Difference -79,950.00

Previous OI 119,300.00

Turnover (₹. Cr.) 121,707,000,178.75

Open price : 550.90

Prev.Close : 511.90

Today High / Low

mrkt-high-low 860 535.80
OPTION CHAIN

SELECT EXPIRY

STRIKE PRICE

ACTIVE CALLS
ACTIVE PUTS
LTP VOLUME CHANGE CHANGE (%) STRIKE PRICE LTP VOLUME CHANGE CHANGE (%)
{{d.ltp_call}} {{d.change_call}} {{d.volume_call}} {{d.changeper_call}} {{d.strikeprice}} {{d.ltp_put}} {{d.change_put}} {{d.changeper_put}} {{d.volume_put}}
Loading
Explore abtrade Mobile investplaystoreappstore

Sign up
for a free Demat account now!

Sign up for a free Demat account now!
Attention Investor
1. KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.          2. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.          3. Prevent Unauthorized Transactions in your demat account:Update your Mobile Number with your Depository Participant/ Stock Broker. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from NSDL / CDSL on the same day………. issued in the interest of investors.          4. For Stock Broking Transaction 'Prevent unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day...Issued in the interest of Investors.          5. Investors should be cautious on unsolicited emails and SMS advising to buy, sell or hold securities and trade only on the basis of informed decision. Investors are advised to invest after conducting appropriate analysis of respective companies and not to blindly follow unfounded rumours, tips etc. Further, you are also requested to share your knowledge or evidence of systemic wrongdoing, potential frauds or unethical behaviour through the anonymous portal facility provided on BSE & NSE website.          6. Email Id for reporting of cyber attacks: abm.cybersecurity@adityabirlacapital.com, Helpline number for reporting of cyber attacks : +91 8045860203.

Show Menu

open an account